*To the Editor:* Asialoglycoprotein receptor 1 (*ASGR1*) is the major of *ASGR*, it is predominantly expressed by liver parenchymal cells and relatively lower expression was found in peripheral blood monocytes.^\[[@R1]\]^ A genetic study recently revealed that *ASGR1* haploinsufficiency resulted from loss-of-function (LOF) variants was strongly associated with the pronounced reductions in serum total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels,^\[[@R2],[@R3]\]^ suggesting that *ASGR1* may play a key role in cholesterol metabolism. However, the function of *ASGR1* remains largely unclear. This study was focused on the association of *ASGR1* gene expression in monocytes and plasma cholesterol level.

This study followed the principles of the *Declaration of Helsinki* and was approved by the Ethics Committee of the First People\'s Hospital of Huaihua, University of South China (KY-2017060101). The written inform consents were obtained from the included individuals.

A total of 104 patients who were hospitalized in Cardiology Department, the First People\'s Hospital of Huaihua from July 1 to August 31, 2017 were recruited. Whole blood samples were collected at the 7 [am]{.smallcaps} after overnight fasting on admission for routine clinical detections and monocytes separation. Demographic and clinical characteristics and laboratory parameters were collected from electronic medical record. The test of *ASGR1* gene in monocytes was referred to the description of previous study.^\[[@R1],[@R4]\]^ Statistical analyses were performed by R ([http://www.R-project.org](http://www.r-project.org/)) and EmpowerStats software ([www.empowerstats.com](http://www.empowerstats.com/), X&Y solutions, Inc., Boston, MA, USA)

The mean age of included patients was 58 years, 34 (33%) were females. The relative expression of *ASGR1* gene ranged from 0.21 to 3.87. When stratified by the tertiles of *ASGR1* gene expression \[Supplementary Table 1\], TC and LDL-C levels were higher in top tertile than those in middle and bottom tertiles (*P* \< 0.001). The differences in *ASGR1* gene expression between subgroups which stratified by age, gender, and clinical diagnoses were not significant, but a lower *ASGR1* gene expression was observed in the subjects with cholesterol-lowering therapy than that in the patients without cholesterol-lowering therapy \[Supplementary Figure 1\].

Single factor linear regression showed log-transformed *ASGR1* gene expression was significantly associated with TC and LDL-C but not associated with the other lipids \[Supplementary Table 2\]. Multiple linear regression after adjusting for gender, clinical diagnoses and cholesterol-lowering therapy showed a pronounced association of *ASGR1* gene expression with TC and LDL-C levels among patients who aged \<60 years \[Table [1](#T1){ref-type="table"}\]. As for 1-SD increase in log-transformed *ASGR1* gene expression, TC increased 2.11 mmol/L (95% CI, 0.61--3.61) and LDL-C increased 1.77 mmol/L (95% CI, 0.65--2.90). When regarded bottom tertile as reference, TC levels increased 0.44 and 1.10 mmol/L from the middle to top tertile, respectively, LDL-C levels increased in parallel with the tertiles of *ASGR1* gene expression (*β* were 0.34 and 0.91 for the middle and top tertile). However, the association was lost the significance among patients aged ≥60 years \[Table [1](#T1){ref-type="table"}\]. Multivariate smoothing spline plots after adjusted for gender, clinical diagnosis, and cholesterol-lowering therapy demonstrated that plasma TC and LDL-C increased with the increasing expression of log-transformed *ASGR1* gene in a linear dose-response manner in patients aged \<60 years but not in patients who aged ≥60 years \[Supplementary Figure 2A and 2B\].
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Multivariable adjusted analysis of the associations between *ASGR1* gene expression and TC and LDL-C.
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*ASGR1* knockout-mice and humans carrying LOF variants of *ASGR1* all displayed a much lower TC and LDL-C levels,^\[[@R2],[@R5]\]^ suggesting that *ASGR1* involves in cholesterol metabolism. Previous study all focused on the hepatic *ASGR1*. Particularly, this study focused on the monocyte *ASGR1* and showed that *ASGR1* gene expression in monocytes was positively associated with plasma TC and LDL-C levels in a dose-response manner in the patients aged \<60 years, indicating that monocyte *ASGR1* may also play a role in cholesterol metabolism. However, the physiological function of *ASGR1* remains unclear.

Monocytes are the source of macrophages. Whether macrophages express functional *ASGR1* is important to clarify the roles of *ASGR1* in cholesterol metabolism. Genetic study showed that LOF variants of *ASGR1* has a larger effect on the risk of coronary artery disease than is anticipated by its effect on the reduced levels of cholesterol.^\[[@R2]\]^ If the LOF variants resulted in a defective functional *ASGR1* both in hepatocyte and in monocytes (macrophages), these phenotypes may be reasonably interpreted. In addition, cholesterol-lowering drugs have a suppressive effect on *ASGR1* gene expression, whether the decreased *ASGR1* gene expression induced by cholesterol-lowering drugs involves in the cholesterol-lowering effect by these drugs deserved to be explored.

Of note, though these findings provide new insights that the monocytes *ASGR1* may play a role in deaminating TC and LDL-C levels, but whether *ASGR1* could be a target for lowering cholesterol, much work has to be done to clarify the molecular mechanism.
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